What now for Johnson & Johnson, as brand-boosting vaccine turns to crisis

Johnson & Johnson’s COVID-19 vaccine started out as a clear boost to the company brand. It was among the earliest to market, the first approved in the U.S. as a single dose—and entirely not-for-profit, as the company began advertising last year.